Find Fibrinogen manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 89105-94-2, Chembl409436, Fibrinogen-binding inhibitor peptide, Dtxsid10433062, Hishisleuglyglyalalysglnalaglyaspval, Bdbm50034686
Molecular Formula
C50H80N18O16
Molecular Weight
1189.3  g/mol
InChI Key
STSKWZSBFZRSGP-GYDGUXFESA-N

Fibrinogen
1 2D Structure

Fibrinogen

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]acetyl]amino]propanoyl]amino]hexanoyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoic acid
2.1.2 InChI
InChI=1S/C50H80N18O16/c1-24(2)13-33(67-48(81)34(15-29-18-55-23-60-29)66-44(77)30(52)14-28-17-54-22-59-28)45(78)58-19-37(70)56-20-38(71)61-27(6)43(76)64-31(9-7-8-12-51)47(80)65-32(10-11-36(53)69)46(79)62-26(5)42(75)57-21-39(72)63-35(16-40(73)74)49(82)68-41(25(3)4)50(83)84/h17-18,22-27,30-35,41H,7-16,19-21,51-52H2,1-6H3,(H2,53,69)(H,54,59)(H,55,60)(H,56,70)(H,57,75)(H,58,78)(H,61,71)(H,62,79)(H,63,72)(H,64,76)(H,65,80)(H,66,77)(H,67,81)(H,68,82)(H,73,74)(H,83,84)/t26-,27-,30-,31-,32-,33-,34-,35-,41-/m0/s1
2.1.3 InChI Key
STSKWZSBFZRSGP-GYDGUXFESA-N
2.1.4 Canonical SMILES
CC(C)CC(C(=O)NCC(=O)NCC(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)O)NC(=O)C(CC1=CN=CN1)NC(=O)C(CC2=CN=CN2)N
2.1.5 Isomeric SMILES
C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CN=CN2)N
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 89105-94-2

2. Chembl409436

3. Fibrinogen-binding Inhibitor Peptide

4. Dtxsid10433062

5. Hishisleuglyglyalalysglnalaglyaspval

6. Bdbm50034686

7. Mfcd00167528

8. Ncgc00167215-01

2.3 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 1189.3 g/mol
Molecular Formula C50H80N18O16
XLogP3-9.7
Hydrogen Bond Donor Count18
Hydrogen Bond Acceptor Count20
Rotatable Bond Count39
Exact Mass1188.59996854 g/mol
Monoisotopic Mass1188.59996854 g/mol
Topological Polar Surface Area547 Ų
Heavy Atom Count84
Formal Charge0
Complexity2310
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

JDMF

read-more
read-more

01

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Human fibrinogen drug substance

Registration Number : 227MF10083

Registrant's Address : 1-6-1 Okubo, Kita-ku, Kumamoto City, Kumamoto Prefecture

Initial Date of Registration : 2015-03-12

Latest Date of Registration : 2016-03-23

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Fibryga is a fibrinogen concentrate which acts as as fibrinogen replacement therapy. It is approved for the treatment of acquired fibrinogen deficiency (AFD).


Lead Product(s): Fibrinogen

Therapeutic Area: Hematology Brand Name: Fibryga

Study Phase: ApprovedProduct Type: Large molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 01, 2024

blank

01

Octapharma

Switzerland
arrow
Duphat
Not Confirmed

Octapharma

Switzerland
arrow
Duphat
Not Confirmed

Details : Fibryga is a fibrinogen concentrate which acts as as fibrinogen replacement therapy. It is approved for the treatment of acquired fibrinogen deficiency (AFD).

Brand Name : Fibryga

Molecule Type : Large molecule

Upfront Cash : Not Applicable

August 01, 2024

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

CSL Behring

U.S.A
Duphat
Not Confirmed
arrow

CSL Behring

U.S.A
arrow
Duphat
Not Confirmed

Human fibrinogen

Brand Name : Haemocomplettan P

Dosage Form : Dry Sub

Dosage Strength : 1g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

CSL Behring

U.S.A
Duphat
Not Confirmed
arrow

CSL Behring

U.S.A
arrow
Duphat
Not Confirmed

Human fibrinogen

Brand Name : Haemocomplettan P

Dosage Form : Dry Sub

Dosage Strength : 2g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Octapharma

Switzerland
Duphat
Not Confirmed
arrow

Octapharma

Switzerland
arrow
Duphat
Not Confirmed

Human fibrinogen

Brand Name : Fibryga

Dosage Form : Trockensub

Dosage Strength : 1g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

Country
Duphat
Not Confirmed
arrow

Country
arrow
Duphat
Not Confirmed

Fibrinogen, human, Thrombin, human

Brand Name : TachoSil

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Packaging : Boks 5 7.5cm2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

05

Country
Duphat
Not Confirmed
arrow

Country
arrow
Duphat
Not Confirmed

Fibrinogen, human, Thrombin, human

Brand Name : TachoSil

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Packaging : Boks 1 45.6cm2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

Country
Duphat
Not Confirmed
arrow

Country
arrow
Duphat
Not Confirmed

Fibrinogen, human, Thrombin, human

Brand Name : TachoSil

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Packaging : Boks 1 7.5cm2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

Country
Duphat
Not Confirmed
arrow

Country
arrow
Duphat
Not Confirmed

Fibrinogen, human, Thrombin, human

Brand Name : TachoSil

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Packaging : Boks 1 23cm2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

Country
Duphat
Not Confirmed
arrow

Country
arrow
Duphat
Not Confirmed

Fibrinogen, human, Thrombin, human

Brand Name : TachoSil

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Packaging : Boks 2 23cm2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Human fibrinogen

Brand Name : Haemocomplettan P

Dosage Form : Dry Sub

Dosage Strength : 1g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

Duphat
Not Confirmed
arrow
arrow
Duphat
Not Confirmed

Human fibrinogen

Brand Name : Haemocomplettan P

Dosage Form : Dry Sub

Dosage Strength : 2g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

Octapharma AG

Switzerland
Duphat
Not Confirmed
arrow

Octapharma AG

Switzerland
arrow
Duphat
Not Confirmed

Human fibrinogen

Brand Name : Fibryga

Dosage Form : Trockensub

Dosage Strength : 1g

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

Corza Medical GmbH

Country
Duphat
Not Confirmed
arrow

Corza Medical GmbH

Country
arrow
Duphat
Not Confirmed

Fibrinogen, human, Thrombin, human

Brand Name : TachoSil

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Packaging : Boks 5 7.5cm2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

05

Corza Medical GmbH

Country
Duphat
Not Confirmed
arrow

Corza Medical GmbH

Country
arrow
Duphat
Not Confirmed

Fibrinogen, human, Thrombin, human

Brand Name : TachoSil

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Packaging : Boks 1 45.6cm2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

Corza Medical GmbH

Country
Duphat
Not Confirmed
arrow

Corza Medical GmbH

Country
arrow
Duphat
Not Confirmed

Fibrinogen, human, Thrombin, human

Brand Name : TachoSil

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Packaging : Boks 1 7.5cm2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

07

Corza Medical GmbH

Country
Duphat
Not Confirmed
arrow

Corza Medical GmbH

Country
arrow
Duphat
Not Confirmed

Fibrinogen, human, Thrombin, human

Brand Name : TachoSil

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Packaging : Boks 1 23cm2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

08

Corza Medical GmbH

Country
Duphat
Not Confirmed
arrow

Corza Medical GmbH

Country
arrow
Duphat
Not Confirmed

Fibrinogen, human, Thrombin, human

Brand Name : TachoSil

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Packaging : Boks 2 23cm2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/drug-delivery/grifols-readies-us-eu-approval-push-blood-clot-treatment-after-phase-3-success

FIERCE PHARMA
15 Feb 2024

https://www.ema.europa.eu/documents/procedural-steps-after/raplixa-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf

EMA
10 Oct 2018

https://www.ema.europa.eu/documents/public-statement/public-statement-raplixa-withdrawal-marketing-authorisation-european-union_en-0.pdf

EMA
10 Oct 2018

https://www.ema.europa.eu/documents/product-information/raplixa-epar-product-information_en.pdf

EMA
10 Oct 2018

https://www.pharmacompass.com/pdf/news/instituto-grifols-sa-veraseal-human-fibrinogen-human-thrombin-receives-approval-in-europe-1516426069.pdf

EMA
19 Jan 2018

Global Sales Information

Do you need Business Intel? Ask us

Finished Drug Prices

read-more
read-more

01

Brand Name : Haemocomplettan P

U.S.A
arrow
Duphat
Not Confirmed

Brand Name : Haemocomplettan P

U.S.A
arrow
Duphat
Not Confirmed

Fibrinogen

Dosage Form : Dry Sub

Dosage Strength : 1g

Price Per Pack (Euro) : 395.51

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

02

Brand Name : Haemocomplettan P

U.S.A
arrow
Duphat
Not Confirmed

Brand Name : Haemocomplettan P

U.S.A
arrow
Duphat
Not Confirmed

Fibrinogen

Dosage Form : Dry Sub

Dosage Strength : 2g

Price Per Pack (Euro) : 791.02

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

03

Brand Name : Fibryga

Switzerland
arrow
Duphat
Not Confirmed

Brand Name : Fibryga

Switzerland
arrow
Duphat
Not Confirmed

Fibrinogen

Dosage Form : Trockensub

Dosage Strength : 1g

Price Per Pack (Euro) : 441.12

Published in :

Country : Switzerland

RX/OTC/DISCN : Class B

blank

04

Brand Name : TachoSil

Country
arrow
Duphat
Not Confirmed

Brand Name : TachoSil

Country
arrow
Duphat
Not Confirmed

Fibrinogen

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Price Per Pack (Euro) : 248.11

Published in :

Country : Norway

RX/OTC/DISCN :

blank

05

Brand Name : TachoSil

Country
arrow
Duphat
Not Confirmed

Brand Name : TachoSil

Country
arrow
Duphat
Not Confirmed

Fibrinogen

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Price Per Pack (Euro) : 214.24

Published in :

Country : Norway

RX/OTC/DISCN :

blank

06

Brand Name : TachoSil

Country
arrow
Duphat
Not Confirmed

Brand Name : TachoSil

Country
arrow
Duphat
Not Confirmed

Fibrinogen

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Price Per Pack (Euro) : 49.62

Published in :

Country : Norway

RX/OTC/DISCN :

blank

07

Brand Name : TachoSil

Country
arrow
Duphat
Not Confirmed

Brand Name : TachoSil

Country
arrow
Duphat
Not Confirmed

Fibrinogen

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Price Per Pack (Euro) : 170.44

Published in :

Country : Norway

RX/OTC/DISCN :

blank

08

Brand Name : TachoSil

Country
arrow
Duphat
Not Confirmed

Brand Name : TachoSil

Country
arrow
Duphat
Not Confirmed

Fibrinogen

Dosage Form : Registration for the future

Dosage Strength : 5.5 mg/cm2/2 IE/cm2

Price Per Pack (Euro) : 249.29

Published in :

Country : Norway

RX/OTC/DISCN :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Fibrinogen Manufacturers

A Fibrinogen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fibrinogen, including repackagers and relabelers. The FDA regulates Fibrinogen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fibrinogen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Fibrinogen Suppliers

A Fibrinogen supplier is an individual or a company that provides Fibrinogen active pharmaceutical ingredient (API) or Fibrinogen finished formulations upon request. The Fibrinogen suppliers may include Fibrinogen API manufacturers, exporters, distributors and traders.

click here to find a list of Fibrinogen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Fibrinogen USDMF

A Fibrinogen DMF (Drug Master File) is a document detailing the whole manufacturing process of Fibrinogen active pharmaceutical ingredient (API) in detail. Different forms of Fibrinogen DMFs exist exist since differing nations have different regulations, such as Fibrinogen USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Fibrinogen DMF submitted to regulatory agencies in the US is known as a USDMF. Fibrinogen USDMF includes data on Fibrinogen's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fibrinogen USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Fibrinogen suppliers with USDMF on PharmaCompass.

Fibrinogen JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Fibrinogen Drug Master File in Japan (Fibrinogen JDMF) empowers Fibrinogen API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Fibrinogen JDMF during the approval evaluation for pharmaceutical products. At the time of Fibrinogen JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Fibrinogen suppliers with JDMF on PharmaCompass.

Fibrinogen GMP

Fibrinogen Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Fibrinogen GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fibrinogen GMP manufacturer or Fibrinogen GMP API supplier for your needs.

Fibrinogen CoA

A Fibrinogen CoA (Certificate of Analysis) is a formal document that attests to Fibrinogen's compliance with Fibrinogen specifications and serves as a tool for batch-level quality control.

Fibrinogen CoA mostly includes findings from lab analyses of a specific batch. For each Fibrinogen CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Fibrinogen may be tested according to a variety of international standards, such as European Pharmacopoeia (Fibrinogen EP), Fibrinogen JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fibrinogen USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty